An Open‐Label Single‐Arm Phase II Study of Treatment with Neoadjuvant S‐1 Plus Cisplatin for Clinical Stage III Squamous Cell Carcinoma of the Esophagus

LESSONS LEARNED: Two courses of neoadjuvant therapy using S‐1 plus cisplatin for clinical stage III esophageal squamous cell carcinoma did not achieve expected response rate according to endoscopic evaluation of primary tumors. Subsequent esophagectomy was safely performed. BACKGROUND: In Japan, eso...

Full description

Saved in:
Bibliographic Details
Published in:Oncologist
Main Authors: Kanda, Mitsuro, Koike, Masahiko, Iwata, Naoki, Shimizu, Dai, Tanaka, Chie, Hattori, Norifumi, Hayashi, Masamichi, Yamada, Suguru, Omae, Kenji, Nakayama, Goro, Kodera, Yasuhiro
Format: Artigo
Language:Inglês
Published: John Wiley & Sons, Inc. 2020
Subjects:
Clinical Trial Results
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7648369/
https://ncbi.nlm.nih.gov/pubmed/32557987
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2020-0546
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items